These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 16343099)
1. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus? Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099 [TBL] [Abstract][Full Text] [Related]
2. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025 [TBL] [Abstract][Full Text] [Related]
3. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623 [TBL] [Abstract][Full Text] [Related]
4. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo. Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467 [TBL] [Abstract][Full Text] [Related]
5. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes. Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863 [TBL] [Abstract][Full Text] [Related]
6. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients. Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons. Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight men. Chan DC; Watts GF; Ng TW; Uchida Y; Sakai N; Yamashita S; Barrett PH Clin Biochem; 2005 Sep; 38(9):806-12. PubMed ID: 15992790 [TBL] [Abstract][Full Text] [Related]
9. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799 [TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941 [TBL] [Abstract][Full Text] [Related]
11. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia. Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549 [TBL] [Abstract][Full Text] [Related]
12. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia. Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056 [TBL] [Abstract][Full Text] [Related]
13. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease. Santos RD; Sposito AC; Ventura LI; Cesar LA; Ramires JA; Maranhão RC Am J Cardiol; 2000 May; 85(10):1163-6. PubMed ID: 10801994 [TBL] [Abstract][Full Text] [Related]
14. The effect of pravastatin on plasma lipoprotein and apolipoprotein levels in primary hypercholesterolemia. The Southeastern Michigan Collaborative Group. Rubenfire M; Maciejko JJ; Blevins RD; Orringer C; Kobylak L; Rosman H Arch Intern Med; 1991 Nov; 151(11):2234-40. PubMed ID: 1953228 [TBL] [Abstract][Full Text] [Related]
15. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247 [TBL] [Abstract][Full Text] [Related]
16. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224 [TBL] [Abstract][Full Text] [Related]
17. Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia. Li JJ; Li YS; Chu JM; Zhang CY; Wang Y; Huang Y; Chen J; Yuan JQ; Huang YL Clin Chim Acta; 2006 Apr; 366(1-2):269-73. PubMed ID: 16343471 [TBL] [Abstract][Full Text] [Related]